Oren Gilad - President/CEO, Director at Aprea Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: President/CEO, Director
Issuer Symbol: APRE on Nasdaq
All Insider Reports: All Insider Reports

Oren Gilad - trading volume in the past year for Aprea Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys	+55,059	100%	$1.09	+$60,119
Sells
Net	+55,059	100%		+$60,119

Holdings reported by Oren Gilad for Aprea Therapeutics, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	373,720	$332,610	$0.8900	30 Jan 2026	Direct
Pre-Funded Warrant	21,459	$24,999	$1.16	10 Dec 2025	Direct	Common Stock
Common Stock	1,200	$1,104	$0.9200	30 Jan 2026	By Daughter
Common Stock	600	$552	$0.9200	30 Jan 2026	By Son
Common Warrant	28,100			30 Jan 2026	Direct	Common Stock
Stock Options (Right to Buy)	26,900			27 Mar 2025	Direct	Common Stock
Common Warrants	21,459			10 Dec 2025	Direct	Common Stock

Transactions reported by Oren Gilad for Aprea Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.